Paul Tudor Jones’s Gilead Sciences GILD Stock Holding History

Paul Tudor Jones’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$28.2M	Buy	222,900 +210,400	+1,683%	+$27.7M	0.04%	352
2026 Q1	$1.74M	Sell	12,500 -4,800	-28%	-$672K	﹤0.01%	1954
2025 Q4	$2.12M	Sell	17,300 -26,500	-61%	-$3.22M	﹤0.01%	1770
2025 Q3	$4.86M	Buy	43,800 +9,500	+28%	+$1.08M	0.01%	1215
2025 Q2	$3.8M	Buy	+34,300	New	+$3.65M	0.01%	1250
2025 Q1	–	Sell	-5,500	Closed	-$508K	–	3282
2024 Q4	$508K	Sell	5,500 -39,700	-88%	-$3.57M	﹤0.01%	2228
2024 Q3	$3.79M	Buy	45,200 +24,900	+123%	+$1.9M	0.01%	858
2024 Q2	$1.39M	Buy	20,300 +12,500	+160%	+$834K	0.01%	1284
2024 Q1	$571K	Sell	7,800 -32,800	-81%	-$2.52M	﹤0.01%	1594
2023 Q4	$3.29M	Buy	+40,600	New	+$3.16M	0.03%	849

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Paul Tudor Jones's GILD Position: Q2 2026 in Review

Paul Tudor Jones increased its Gilead Sciences (GILD) stake by 28% in Q2 2026, buying an estimated $2.18M and bringing the position to 74,896 shares worth $9.46M. The position accounts for 0.01% of the portfolio, ranked #857.

Paul Tudor Jones first reported a position in GILD in Q2 2013 and has held it in 40 quarters since. The position peaked at $35.7M in Q2 2024. 2,265 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Paul Tudor Jones held 74,896 shares of Gilead Sciences worth $9.46M as of Q2 2026.
Paul Tudor Jones bought 16,527 Gilead Sciences shares in Q2 2026, an estimated $2.18M.
Gilead Sciences made up 0.01% of Paul Tudor Jones's portfolio in Q2 2026, its #857 holding.
Paul Tudor Jones first reported a position in Gilead Sciences in Q2 2013 and has held it in 40 quarters since.
Paul Tudor Jones's Gilead Sciences position peaked at $35.7M in Q2 2024.
2,265 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.